OTC Review 2022 – Plan with confidence so you and your brands can shine
In an age of uncertainty, you need insights you can trust so you can plan with confidence, enabling you and your brands to shine.
The pandemic does not appear to have had a negative impact on top-line sales of OTC products, despite subdued consumer spending. Indeed, global sales remained buoyant in both 2020 and 2021, increasing in the latter year by 6%. Growth was driven in part by a shift in consumer health behaviour towards healthcare prevention and self-care, although the market by value was also boosted by price hikes associated with rising manufacturing and distribution costs.
IQVIA Consumer Health’s OTC Review 2022 is your guide through these volatile times, helping you to understand the OTC market for 51 countries and 6 OTC categories, covering:
- Cough, Cold, and Respiratory
- Digestive
- Pain Relief
- Skin Treatment
- Vitamins, Minerals & Supplements, and
- Other OTC
OTC Review 2022 is fully customisable to your needs, giving you audited, trustworthy market data and forecasts for your countries and categories, so you can plan smarter and invest better in today’s dynamic consumer health market.
To purchase this report, please complete the form on this page to make an enquiry and receive a quote from your local IQVIA Consumer Health representative.
Copyright © 2025 IQVIA Holdings Inc. and its affiliates. All rights reserved. Privacy Statement
